Loading…
Bioceres Crop Solutions Corp. is projected to rise to $0.5523 by 2027, a +32% move from its current price of $0.417. BIOX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.395 | $0.4171 | $0.4403 | +0.02% |
| May 30 | $0.3863 | $0.4171 | $0.4504 | +0.03% |
| May 31 | $0.3798 | $0.4172 | $0.4583 | +0.05% |
| Jun 1 | $0.3744 | $0.4173 | $0.4651 | +0.07% |
| Jun 2 | $0.3697 | $0.4174 | $0.4712 | +0.08% |
| Jun 3 | $0.3655 | $0.4174 | $0.4768 | +0.10% |
| Jun 4 | $0.3617 | $0.4175 | $0.4819 | +0.12% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3617 | $0.4175 | $0.4819 | +0.12% |
| Week 2 | $0.3412 | $0.418 | $0.5121 | +0.24% |
| Week 3 | $0.3264 | $0.4185 | $0.5366 | +0.36% |
| Week 4 | $0.3144 | $0.419 | $0.5583 | +0.47% |
| Week 5 | $0.3043 | $0.4195 | $0.5783 | +0.59% |
| Week 6 | $0.2955 | $0.42 | $0.597 | +0.71% |
| Week 7 | $0.2876 | $0.4205 | $0.6147 | +0.83% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops.
The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program.
The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.
Bioceres Crop Solutions Corp. (BIOX) is categorized in Basic Materials. The stock currently trades at $0.4139 with a market capitalization of $26.41M and holds a rank of 4859. The price outlook derived from the provided forecast shows a neutral stance for 2026, followed by bullish momentum in 2027–2029 and continuing bullish sentiment into 2034–2050, with varying min/avg/max targets and rising ROI.
The forecast highlights the potential for growth across multiple future years, culminating in a 2050 max target of $3.44 and a 261.6% ROI.
A major floor 42.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.9% away) — a key level to hold.
The nearest ceiling, 60.2% above — a clean break opens room to run.
A major ceiling 211.8% above — clearing it would confirm fresh momentum.
Key BIOX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BIOX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.4224 | Sell | $0.4214 | Sell |
| MA 10 | $0.4257 | Sell | $0.4319 | Sell |
| MA 20 | $0.4503 | Sell | $0.4541 | Sell |
| MA 50 | $0.4845 | Sell | $0.5212 | Sell |
| MA 100 | $0.6609 | Sell | $0.7591 | Sell |
| MA 200 | $1.27 | Sell | $1.54 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.88 | Neutral |
| Stoch RSI (14) | 19.32 | Buy |
| CCI (20) | -88.99 | Neutral |
| Williams %R (14) | -94.03 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -11.28 | Sell |
| Bollinger %B (20,2) | 0.24 | Neutral |
| Stochastic %K (14) | 5.97 | Buy |
| TRIX (15) | -0.73 | Sell |
| Awesome (5,34) | -0.08 | Sell |
| Ultimate (7,14,28) | 40.11 | Neutral |
| Momentum (10) | -0.03 | Sell |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 0.42 | Buy |
| ADX (14) | 15.20 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is bearish. RSI14 is 40, indicating modest negative momentum. The stock trades with a trailing bias relative to its shorter and longer-term moving averages, with SMA50 at $0.4871 and SMA200 at $1.30.
Near-term support sits at $0.409 while resistance is placed at $0.668. The 30-day range spans from $0.283 to $0.6053, underscoring a tight, price-constrained window over the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.371 | $0.417 | $0.6087 | 0% | Neutral | |
| $0.3975 | $0.5523 | $0.8305 | +32% | Bullish | |
| $0.3722 | $0.5488 | $0.8773 | +32% | Bullish | |
| $0.357 | $0.5541 | $0.9287 | +33% | Bullish | |
| $0.3197 | $0.52 | $0.9066 | +25% | Bullish | |
| $0.2816 | $0.4787 | $0.8633 | +15% | Neutral | |
| $0.2645 | $0.4688 | $0.8715 | +12% | Neutral | |
| $0.2669 | $0.4925 | $0.9406 | +18% | Neutral | |
| $0.3691 | $0.7085 | $1.39 | +70% | Bullish | |
| $0.3856 | $0.7692 | $1.54 | +84% | Bullish | |
| $0.3442 | $0.765 | $1.68 | +83% | Bullish | |
| $0.6795 | $1.51 | $3.47 | +262% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.371 | $0.417 | $0.4905 | +0.00% |
| June 2026 | $0.3335 | $0.3999 | $0.497 | -4.10% |
| July 2026 | $0.3472 | $0.4235 | $0.5397 | +5.89% |
| August 2026 | $0.3426 | $0.4235 | $0.5503 | +0.01% |
| September 2026 | $0.3223 | $0.4027 | $0.5315 | -4.91% |
| October 2026 | $0.3346 | $0.4225 | $0.5653 | +4.90% |
| November 2026 | $0.3574 | $0.4553 | $0.6167 | +7.78% |
| December 2026 | $0.3457 | $0.4443 | $0.6087 | -2.42% |
Click any year to see its month-by-month BIOX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The BIOX price prediction for 2026 points to an average of $0.417 (low $0.371, high $0.6087) — a potential gain of 0% on today's $0.417. A consolidation phase looks the most probable path here.
In 2027, BIOX is projected to trade between $0.3975 and $0.8305, averaging $0.5523 — a potential gain of +32% from today's $0.417. That is up +32% on the projected 2026 average. Momentum favours further upside here.
Bioceres Crop Solutions Corp.'s 2028 outlook centres on $0.5488, within a $0.3722 to $0.8773 range. That is -1% versus the projected 2027 average. That marks a +32% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, BIOX could reach as high as $0.9287, with a base case around $0.5541 and support toward $0.357 — roughly +33% from $0.417. Momentum favours further upside here.
Expect BIOX to range from $0.3197 to $0.9066 through 2030. The $0.52 average target implies a +25% move from current prices. That is -6% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
The BIOX price prediction for 2031 points to an average of $0.4787 (low $0.2816, high $0.8633) — a potential gain of +15% on today's $0.417. Price action looks broadly range-bound.
In 2032, BIOX is projected to trade between $0.2645 and $0.8715, averaging $0.4688 — a potential gain of +12% from today's $0.417. That is -2% versus the projected 2031 average. A consolidation phase looks the most probable path here.
Bioceres Crop Solutions Corp.'s 2033 outlook centres on $0.4925, within a $0.2669 to $0.9406 range. That is up +5% on the projected 2032 average. That marks a +18% change versus current levels. Price action looks broadly range-bound.
By 2034, BIOX could reach as high as $1.39, with a base case around $0.7085 and support toward $0.3691 — roughly +70% from $0.417. Buyers look set to stay in control over this stretch.
Expect BIOX to range from $0.3856 to $1.54 through 2035. The $0.7692 average target implies a +84% move from current prices. That is up +9% on the projected 2034 average. Momentum favours further upside here.
The BIOX price prediction for 2040 points to an average of $0.765 (low $0.3442, high $1.68) — a potential gain of +83% on today's $0.417. Buyers look set to stay in control over this stretch.
In 2050, BIOX is projected to trade between $0.6795 and $3.47, averaging $1.51 — a potential gain of +262% from today's $0.417. That is up +97% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in BIOX today (≈ 2,398.081535 BIOX) could be worth
$3,621.27
+$2,621.27 (+262%) by 2050 · US Dollar
Based on the average projected BIOX price of $1.51 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BIOXwould be worth at today's price.
$1,000 invested in BIOX on May 27, 2025 (≈ 193.798455 BIOX) would be worth
$80.81
-$919.19 (-91.9%) today · 0.08× · US Dollar
Based on a BIOX entry price of $5.16 vs. today's $0.417.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.43 | $969.77 | -3.0% |
| 1 month ago | $0.523 | $797.32 | -20.3% |
| 3 months ago | $0.55 | $758.18 | -24.2% |
| 6 months ago | $1.72 | $242.44 | -75.8% |
| 1 year ago | $5.16 | $80.81 | -91.9% |
| All time (5.0y) ago | $15.1 | $27.62 | -97.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BIOX forecast.
Our base-case forecast reaches $0.83 around 2050.
Implied market cap at $0.83: $52.97M
The multi-year forecast shows a path of gradual price progression with scattered milestones. For 2026, min $0.371, avg $0.4139, max $0.6007 and ROI 0, with a Neutral sentiment. Beginning in 2027, the asset is forecast to move into a Bullish stance, with avg prices of $0.5576 (2027), $0.5509 (2028), and $0.5494 (2029), producing ROI of 34.7%, 33.1%, and 32.7% respectively.
In 2030, the min $0.3222, avg $0.5244, max $0.9146, with ROI 26.7 and Bullish sentiment. The years 2031 and 2032 carry Neutral sentiment with min prices around $0.2784 and $0.2577, avg around $0.4734 and $0.457, and max near $0.8542 and $0.8498. The forecast turns Bullish again in 2033 with avg $0.4978 and max $0.9511 (ROI 20.3).
Strong Bullish momentum continues in 2034 (min $0.3714, avg $0.7133, max $1.40, ROI 72.3) and 2035 (min $0.3833, avg $0.7651, max $1.53, ROI 84.8). By 2040, the forecast shows min $0.3436, avg $0.7636, max $1.68 with ROI 84.5 under Bullish sentiment. The long arc ends with a highly bullish 2050 scenario: min $0.6735, avg $1.50, max $3.44, ROI 261.6.
Tap a question to reveal the answer.
In 2030 the forecast gives min $0.3222, avg $0.5244, max $0.9146 with ROI 26.7 and a Bullish sentiment.
The forecast shows positive ROI in multiple years, such as 2027 (34.7%), 2028 (33.1%), 2029 (32.7%), 2034 (72.3%), 2035 (84.8%), 2040 (84.5%), and 2050 (261.6%), with Bullish sentiment in many of these years, though some years are Neutral.
Yes. The 2050 forecast lists a max of $3.44, and earlier years show rising averages (e.g., 2034 avg $0.7133 and 2035 avg $0.7651), indicating potential to exceed $1 by 2050 under the forecast.
The current price is $0.4139, the market capitalization is $26.41M, and the rank is 4859.
Bearish sentiment with RSI 14 at 40. The 30-day range is $0.283 to $0.6053, with SMA50 at $0.4871 and SMA200 at $1.30. Support is at $0.409 and resistance at $0.668.
Bioceres Crop Solutions Corp. Community Discussion
0Share your Bioceres Crop Solutions Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.